Women’s Health Watch: SCOTUS Recap
- July 26, 2024
Delphine O’Rourke, CEO, 8Fold Inc., speaks with Ramona Thomas, General Counsel & Vice President of Risk and Compliance, Planned Parenthood of Orange and San Bernardino Counties, about the recent Supreme Court decisions that impact women’s health. They discuss FDA v. AHM and the use of mifepristone in medication abortions, Moyle v. United States and the conflict between Idaho’s abortion law and EMTALA, and Loper Bright Enterprises v. Raimondo and the end of Chevron deference. They also discuss the practical impacts of these decisions on health care providers and what to expect over the next few months.
You must be logged in to access this content.